{
    "2014-09-10": [
        "Celgene: Releases Data from Phase III First Trial of Revlimid $CELG",
        "Celgene Corp (CELG) 92.93 Final Glance: Biotechnology companies AP - Tue Sep 09, 7:15PM CDT NEW YORK (AP)",
        "GILLA KAPLAN of Celgene Corporation Sells $2,594,475 Worth of $CELG #Form4 #InsiderTrading"
    ]
}